Pharmafile Logo

Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas

Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and opportunities for biopharmaceutical companies developing innovative treatments.

- PMLiVE

At Fishawack Health (FH), we are committed to investing in the field of dermatology. In November 2021, we welcomed FIDE, an independent network of expert partners in dermatology, to inform industry specialists as to the potential impact of the latest data and how it may affect their strategic decision making. FIDE joins other Expert Partnerships at FH including IHEP, which specializes in diseases of the liver and i-ONE, which specializes in oncology and hematology. Each Expert Partnership offers unparalleled access to the latest insights from the world’s leading key opinion leaders.

FIDE’s services range from detailed, unbiased conference analysis programs to consulting and training initiatives that bridge the gap between industry’s understanding of the field and real-world clinician and patient perspectives.

We sat down with members of the FIDE Steering Committee to explore the latest key insights and trends in 5 inflammatory skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa. They examined the complexities of the space and outlined the challenges that new and innovative treatments and technologies can help address, from meeting unmet needs to improving in the provision of high standards of clinical care.

CLICK HERE TO DOWNLOAD FULL ARTICLE

This content was provided by Avalere Health

Company Details

 Latest Content from  Avalere Health 

What does the future hold for Medical Affairs?

Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.

Unpacking rare diseases in the first edition of Delta magazine

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization.

Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting

Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEOR consulting leader with significant expertise in US, EU, and Asia-Pacific markets

Fishawack acquires creative consultancy Blue Latitude Health

The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy...

Fishawack launches new website and introduces new structure for growth

The Fishawack Group has launched their new website, introducing the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative. The new site showcases the Group's capabilities as well as...